Tech Company Financing Transactions

QuantHealth Funding Round

On 1/9/2024, QuantHealth secured funding from Accenture Ventures and private investors.

Transaction Overview

Company Name
Announced On
1/9/2024
Transaction Type
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
The new capital will enable the company to enhance its platform.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
10 Karlibach St, 1st floor
Tel Aviv, Undisclosed
IL
Phone
Undisclosed
Email Address
Overview
Developer of artificial intelligence-based drug development data software designed to conduct patient-centric drug simulations to accelerate and de-risk drug development. The company combines data points from across the clinical and drug development spectrum, provides an AI platform that can predict patient response to both approved and novel therapies, allowing pharma and biotech customers to run variations of their clinical trials to optimize the trial design and increase the probability of trial success, all while enabling discovery of new clinical opportunities and optimization strategies.
Profile
QuantHealth LinkedIn Company Profile
Social Media
QuantHealth Company Twitter Account
Company News
QuantHealth News
Facebook
QuantHealth on Facebook
YouTube
QuantHealth on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Orr Inbar
  Orr Inbar LinkedIn Profile  Orr Inbar Twitter Account  Orr Inbar News  Orr Inbar on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/9/2024: ArenaX Labs venture capital transaction
Next: 1/9/2024: Rewst venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary